跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 7,006 条关于
“HER2 alterations”
全部
7,006
临床试验
4,739
药物
318
机构
9
资讯
1,940
去年
Expert Emphasizes Critical Need for Comprehensive NGS Testing to Detect HER2 Alterations in NSCLC
去年
Bayer's BAY 2927088 Advances to Phase 3 Trial for HER2-Mutated NSCLC
去年
Distinct Mechanisms of HER2-Targeting Agents in NSCLC: Understanding TKIs vs ADCs
9个月前
HER2 Amplification Linked to Worse Outcomes in First-Line Metastatic Colorectal Cancer Treatment
去年
Evolving Landscape of HER2-Directed Tumor-Agnostic Therapies Shows Promise in Cancer Treatment
9个月前
Palbociclib Triple Therapy Shows Significant Survival Benefit in HER2-Positive Breast Cancer Trial
去年
FDA Grants Priority Review to Boehringer's Zongertinib for HER2-Mutant Advanced Lung Cancer
2年前
Zongertinib Shows Promise in HER2-Mutated NSCLC: Boehringer Ingelheim Reports Positive Phase Ib Results
去年
SORT Nanoparticles Enable Durable In Vivo Gene Editing in Lung Stem Cells
去年
FDA Rejects Poziotinib for HER2-Mutated NSCLC Following Advisory Committee's Negative Vote
第 1 页,共 194 页
上一页
下一页